AnaptysBio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.

About ANAB

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. 

CEO
Daniel R. Faga
CEODaniel R. Faga
Employees
136
Employees136
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2005
Founded2005
Employees
136
Employees136

ANAB Key Statistics

Market cap
598.77M
Market cap598.77M
Price-Earnings ratio
-4.21
Price-Earnings ratio-4.21
Dividend yield
Dividend yield
Average volume
486.56K
Average volume486.56K
High today
$20.73
High today$20.73
Low today
$19.98
Low today$19.98
Open price
$20.42
Open price$20.42
Volume
93.62K
Volume93.62K
52 Week high
$41.31
52 Week high$41.31
52 Week low
$12.21
52 Week low$12.21

Analyst ratings

75%

of 12 ratings
Buy
75%
Hold
25%
Sell
0%

People also own

Based on the portfolios of people who own ANAB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.